Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-reported Goal Attainment with Tolterodine ER in Female Overactive Bladder
NCT00836381Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Feb 2009
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolterodine in overactive bladder (OAB), sponsored by Samsung Medical Center. Started Feb 2009; status: completed.
02
Drugs
tolterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00836381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00836381.